PT88985A - Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina - Google Patents

Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina

Info

Publication number: PT88985A
Authority: PT; Portugal
Prior art keywords: nasal; preparation; pharmaceutical compositions; compositions containing; ophthalmic pharmaceutical
Prior art date: 1987-11-13

Application number

PT88985A

Other languages

English (en)

Other versions

PT88985B (pt

Inventor

Helmut Hettche

Original Assignee

Asta Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-13

Filing date

1988-11-11

Publication date

1988-12-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340483&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT88985(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-11-11 Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag

1988-12-01 Publication of PT88985A publication Critical patent/PT88985A/pt

1993-01-29 Publication of PT88985B publication Critical patent/PT88985B/pt

Links

MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 title abstract 3
229960004574 azelastine Drugs 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Immunology (AREA)
Otolaryngology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT88985A 1987-11-13 1988-11-11 Processo para a preparacao de composicoes farmaceuticas nasais e/ou oftalmicas contendo azelastina PT88985B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3738681		1987-11-13

Publications (2)

Publication Number	Publication Date
PT88985A true PT88985A (pt)	1988-12-01
PT88985B PT88985B (pt)	1993-01-29

Family

ID=6340483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT88985A PT88985B (pt)	1987-11-13	1988-11-11	Processo para a preparacao de composicoes farmaceuticas nasais e/ou oftalmicas contendo azelastina

Country Status (15)

Country	Link
US (1)	US5164194A (pt)
EP (1)	EP0316633B1 (pt)
JP (3)	JP2911460B2 (pt)
AT (1)	ATE84968T1 (pt)
AU (1)	AU613107B2 (pt)
CA (1)	CA1319322C (pt)
DE (1)	DE3877904D1 (pt)
DK (1)	DK174928B1 (pt)
ES (1)	ES2053678T3 (pt)
GR (1)	GR3007202T3 (pt)
IE (1)	IE61562B1 (pt)
NL (1)	NL990011I1 (pt)
PT (1)	PT88985B (pt)
YU (1)	YU46988B (pt)
ZA (1)	ZA888461B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE68347T1 (de) *	1987-01-17	1991-11-15	Asta Pharma Ag	Synergistische kombination von azelastin und theophyllin oder azelastin und beta-mimetika.
US5897858A (en)	1994-02-03	1999-04-27	Schering-Plough Healthcare Products, Inc.	Nasal spray compositions exhibiting increased retention in the nasal cavity
US5976573A (en) *	1996-07-03	1999-11-02	Rorer Pharmaceutical Products Inc.	Aqueous-based pharmaceutical composition
JP4138910B2 (ja)	1997-07-02	2008-08-27	帝國製薬株式会社	経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2005281315A (ja) *	1997-07-02	2005-10-13	Aventis Pharmaceuticals Holdings Inc	水性薬理組成物
US6080783A (en) *	1998-09-01	2000-06-27	Gum Tech International, Inc.	Method and composition for delivering zinc to the nasal membrane
EP1243271A1 (en) *	1999-11-11	2002-09-25	Takeda Chemical Industries, Ltd.	Nasal drops containing fused pyridazine derivatives
WO2001052818A1 (en) *	2000-01-19	2001-07-26	Pharmaceutical Discovery Corporation	Dry powder formulations of antihistamine for nasal administration
DE10007203A1 (de)	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
DE20009841U1 (de) *	2000-05-31	2001-10-25	Phyt Immun Gmbh	Nasensalbe auf Basis von Vaselin
JP3450805B2 (ja)	2000-08-08	2003-09-29	わかもと製薬株式会社	水性医薬組成物
WO2002056876A2 (en) *	2001-01-18	2002-07-25	Medpointe Healthcare Inc.	Treatment for snoring
US7977376B2 (en) *	2001-06-27	2011-07-12	Novartis Ag	Olopatadine formulations for topical nasal administration
TWI231759B (en) *	2001-06-27	2005-05-01	Alcon Inc	Olopatadine formulations for topical administration
US6641799B2 (en)	2002-04-03	2003-11-04	Nos Spray, Inc.	Nasal spray for decongesting nasal passages
GB2389530B (en) *	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
CN1674916A (zh)	2002-08-30	2005-09-28	奥坦纳医药公司	环缩松与抗组胺药的组合用于治疗变应性鼻炎的用途
WO2005016275A2 (en) *	2003-08-05	2005-02-24	3M Innovative Properties Company	Formulations containing an immune response modifier
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
RU2006132043A (ru) *	2004-02-06	2008-03-20	МЕДА Фарма ГмбХ унд Ко.КГ (DE)	Комбинация и фармацевтический препарат для лечения ринита
DK2522365T3 (en)	2004-11-24	2017-02-06	Meda Pharmaceuticals Inc	Compositions comprising azelastine and methods for its use
US8758816B2 (en) *	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
GB2423711B (en)	2005-10-24	2007-02-14	Fortune Apex Dev Ltd	Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US7378082B1 (en) *	2007-11-05	2008-05-27	Inspire Pharmaceuticals, Inc.	Method for treating allergic rhinitis without adverse effects
ES2493641T3 (es) *	2007-06-28	2014-09-12	Cydex Pharmaceuticals, Inc.	Administración nasal de soluciones acuosas de corticosteroides
CA2710271A1 (en) *	2007-12-21	2009-07-09	Schering-Plough Healthcare Products, Inc.	Enhancing photostabilization of oxymetazoline
US8642069B2 (en) *	2008-08-27	2014-02-04	Alexander D. Goldin	Composition and method for treating colds
KR101261230B1 (ko) *	2010-11-29	2013-05-07	한림제약(주)	모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
CA2906008C (en)	2013-03-13	2019-07-09	Flatley Discovery Lab, Llc	Pyridazinone compounds and methods for the treatment of cystic fibrosis
EP3061501A1 (en)	2015-02-27	2016-08-31	Rottapharm Ltd.	Composition for the treatment of acne
EP3117825A1 (en)	2015-07-16	2017-01-18	Rottapharm S.p.A.	Oral formulation comprising berberine and morus alba extract
KR102192384B1 (ko) *	2018-12-17	2020-12-17	최연서	광원이 회전 가능한 cob형 led 조명 장치
AU2021291684A1 (en)	2020-06-15	2022-12-08	Alkem Laboratories Limited	Combination of alcaftadine and a corticosteroid
MX2023011546A (es)	2021-04-01	2023-10-06	Alkem Laboratories Ltd	Composiciones nasales que comprenden alcaftadina.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US158564A (en) *		1875-01-12		Improvement in medicine-droppers
US2119643A (en) *	1934-11-07	1938-06-07	Mendl Viktor	Pressure-operated diffuser of toilet-liquids
US2136940A (en) *	1936-07-02	1938-11-15	Aromel Corp	Atomizer
US2457024A (en) *	1945-02-13	1948-12-21	Arp Claus	Collapsible tube holder
US2995308A (en) *	1958-09-23	1961-08-08	American Home Prod	Jet stream dispenser
CH572914A5 (pt) *	1971-01-22	1976-02-27	Asta Werke Ag Chem Fab
US3813384A (en) *	1972-01-17	1974-05-28	Asta Werke Ag Chem Fab	Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
ATE49205T1 (de) *	1984-09-14	1990-01-15	Asta Pharma Ag	Substituierte benzylphthalazinon-derivate.
DE3530793A1 (de) *	1984-09-14	1986-03-27	Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld	Substituierte benzylphthalazinon-derivate
US4769369A (en) *	1986-11-14	1988-09-06	Pennwalt Corporation	Anti-allergy 1(2H)-phthalazinones

1988
- 1988-10-27 AT AT88117902T patent/ATE84968T1/de active
- 1988-10-27 ES ES88117902T patent/ES2053678T3/es not_active Expired - Lifetime
- 1988-10-27 DE DE8888117902T patent/DE3877904D1/de not_active Revoked
- 1988-10-27 EP EP88117902A patent/EP0316633B1/de not_active Revoked
- 1988-11-10 YU YU209288A patent/YU46988B/sh unknown
- 1988-11-10 JP JP63282639A patent/JP2911460B2/ja not_active Expired - Lifetime
- 1988-11-10 CA CA000582817A patent/CA1319322C/en not_active Expired - Lifetime
- 1988-11-11 AU AU25063/88A patent/AU613107B2/en not_active Expired
- 1988-11-11 IE IE340388A patent/IE61562B1/en not_active IP Right Cessation
- 1988-11-11 DK DK198806301A patent/DK174928B1/da not_active IP Right Cessation
- 1988-11-11 ZA ZA888461A patent/ZA888461B/xx unknown
- 1988-11-11 PT PT88985A patent/PT88985B/pt not_active IP Right Cessation
1990
- 1990-07-12 US US07/551,644 patent/US5164194A/en not_active Expired - Lifetime
1993
- 1993-03-02 GR GR930400447T patent/GR3007202T3/el unknown
1997
- 1997-12-26 JP JP9359963A patent/JP2956029B2/ja not_active Expired - Lifetime
1999
- 1999-01-28 JP JP01995599A patent/JP3207816B2/ja not_active Expired - Lifetime
- 1999-04-01 NL NL990011C patent/NL990011I1/nl unknown

Also Published As

Publication number	Publication date
CA1319322C (en)	1993-06-22
JP2911460B2 (ja)	1999-06-23
YU46988B (sh)	1994-09-09
ATE84968T1 (de)	1993-02-15
DE3877904D1 (de)	1993-03-11
JPH01153639A (ja)	1989-06-15
IE883403L (en)	1989-05-13
IE61562B1 (en)	1994-11-16
PT88985B (pt)	1993-01-29
JPH10182464A (ja)	1998-07-07
DK630188A (da)	1989-05-14
DK174928B1 (da)	2004-03-01
ZA888461B (en)	1989-08-30
NL990011I1 (nl)	1999-07-01
AU613107B2 (en)	1991-07-25
EP0316633A1 (de)	1989-05-24
JP3207816B2 (ja)	2001-09-10
AU2506388A (en)	1989-05-18
DK630188D0 (da)	1988-11-11
YU209288A (en)	1990-04-30
EP0316633B1 (de)	1993-01-27
US5164194A (en)	1992-11-17
JP2956029B2 (ja)	1999-10-04
GR3007202T3 (pt)	1993-07-30
JPH11349484A (ja)	1999-12-21
ES2053678T3 (es)	1994-08-01

Legal Events

Date	Code	Title	Description
1993-01-29	FG3A	Patent granted, date of granting	Effective date: 19920730
1999-03-31	TE3A	Change of address (patent)	Owner name: ASTA MEDICA AKTIENGESELLSCHAFT Effective date: 19990106
2002-11-29	PC3A	Transfer or assignment	Free format text: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG DE Effective date: 20020909
2002-11-29	PD3A	Change of proprietorship	Free format text: VIATRIS GMBH & CO. KG DE Effective date: 20020909 Free format text: ASTA MEDICA GMBH DE Effective date: 20020909
2005-06-30	TE3A	Change of address (patent)	Free format text: VIATRIS GMBH & CO. KG DE Effective date: 20050506
2007-06-18	PD4A	Change of proprietorship	Owner name: MEDA PHARMA GMBH & CO. KG, DE Effective date: 20070604
2008-11-24	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20081111

Publication	Publication Date	Title
PT88985A (pt)	1988-12-01	Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
ES2061799T3 (es)	1994-12-16	Nuevo preparado medicamentoso y procedimiento para su preparacion.
ATE204178T1 (de)	2001-09-15	Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ES2084579T3 (es)	1996-05-16	Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
DE69005951D1 (de)	1994-02-24	Medikamente enthaltend Salmeterol und Fluticason.
ES554967A0 (es)	1987-12-16	Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
HUP0002373A2 (hu)	2000-10-28	Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
BR9401199A (pt)	1994-10-18	Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
ATE92762T1 (de)	1993-08-15	Medikamente.
AU1935788A (en)	1989-03-09	A process for producing an administration and/or dosage form for medically active ingredients of drugs
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
PT90308A (pt)	1989-11-10	Processo para a preparacao de composicoes farmaceuticas contendo azelastina com libertacao controlada da substancia activa
ES2059312T3 (es)	1994-11-16	Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
EG19302A (en)	1994-11-30	Compound with gastric acid inhibitory effect and process for its preparation
DK429480A (da)	1981-04-13	Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
AR006202A1 (es)	1999-08-11	Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene
NO892015D0 (no)	1989-05-19	Fremgangsmaate for fremstilling av et legemiddel.
PT97052A (pt)	1991-10-31	Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
KR880002535A (ko)	1988-05-09	약제로서의 15-데옥시스퍼구알린의 용도
BR9809127A (pt)	2000-08-01	Combinação, formulação farmacêutica, processo para o tratamento de uma infecção por hiv em um animal infectado, uso de (-) -(1s,4r)-4-[2-amino-6-(ciclopropil amino)-9h-purin-9-il)-2-ciclopenteno-1-metanol, e, pacote de paciente
GR3019176T3 (en)	1996-06-30	Medicament containing a combination of AZT and amantadin for the treatment of AIDS.
BR9101544A (pt)	1991-12-10	Processo de preparacao de uma composicao contendo hexetidina ou seus derivados ou sais e sua utilizacao
BR9809124A (pt)	2000-08-01	Combinação, formulação, farmacêutica, processo para o tratamento de uma infecção por hiv em um animal, infectado, uso de (-)-(1s, 4r)-4-[2-amino-6-(ciclopropilamino)-9h-purin-9-il)-2-cicl openteno-1-metanol, e, pacote de paciente
ATE12649T1 (de)	1985-04-15	Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate.